Amylin at the Interface between Metabolic and Neurodegenerative Disorders
The pancreatic peptide amylin is best known for its role as a satiation hormone in the control of food intake and as the major component of islet amyloid deposits in the pancreatic islets of patients with type 2 diabetes mellitus (T2DM). Epidemiological studies have established a clear association b...
Main Authors: | Thomas Alexander Lutz, Urs eMeyer |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2015-06-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fnins.2015.00216/full |
Similar Items
-
Mono and dual agonists of the amylin, calcitonin, and CGRP receptors and their potential in metabolic diseases
by: Nina Sonne, et al.
Published: (2021-04-01) -
Relation between serum amylin level and epilepsy
by: Necla Benlier, et al.
Published: (2020-03-01) -
Role of Biliverdin Reductase A in the Regulation of Insulin Signaling in Metabolic and Neurodegenerative Diseases: An Update
by: Flavia Agata Cimini, et al.
Published: (2022-05-01) -
The Role of NADPH Oxidases and Oxidative Stress in Neurodegenerative Disorders
by: Anuradha Tarafdar, et al.
Published: (2018-11-01) -
The nutrition and immunity (nutrIMM) study: protocol for a non-randomized, four-arm parallel-group, controlled feeding trial investigating immune function in obesity and type 2 diabetes
by: Jenneffer Rayane Braga Tibaes, et al.
Published: (2023-09-01)